Humana (HUM) EBIT (2009 - 2026)

Humana's EBIT history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, EBIT fell 12.91% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $2.4 billion (down 26.83% YoY), while the FY2025 annual figure was $2.7 billion, up 5.54% from the prior year.
• EBIT was $1.8 billion for Q1 2026 at Humana, up from -$808.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $2.0 billion in Q1 2025 to a low of -$808.0 million in Q4 2025.
• Historically, EBIT has averaged $872.5 million across 5 years, with a median of $1.2 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: EBIT jumped 3651.52% in 2022, then slumped 380.65% in 2023.
• A 5-year view of EBIT shows it stood at $124.0 million in 2022, then plunged by 380.65% to -$348.0 million in 2023, then sank by 56.03% to -$543.0 million in 2024, then plunged by 48.8% to -$808.0 million in 2025, then surged by 317.08% to $1.8 billion in 2026.
• The last three EBIT figures came in at $1.8 billion (Q1 2026), -$808.0 million (Q4 2025), and $400.0 million (Q3 2025), per Business Quant data.